SCHEMBL3845935

SCHEMBL3845935

COC(=O)c1ncnc2ccc(Br)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.56
TSHR P16473 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.51
ALDH1A1 P00352 3/20 0.51
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MAPT P10636 1/20 0.48
CCNC P24863 1/20 0.48
CDK8 P49336 1/20 0.48
EGFR P00533 2/20 0.47
ALK Q9UM73 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
ELANE P08246 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29249689 0.83 GABRP (0.45) HTTTSHRALDH1A1MAPTEGFR
SCHEMBL21756436 0.81 KDM4E (0.53) HTTTSHRL3MBTL1ALDH1A1LMNA
Ammonia Solution, Strong SCHEMBL3853118 0.80 KDM4E (0.52) HTTTSHRL3MBTL1ALDH1A1LMNA
SCHEMBL3846705 0.79 LMNA (0.51) HTTTSHRALDH1A1LMNASMN1; SMN2
SCHEMBL15500822 0.78 RXFP1 (0.51) TSHRALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL29680913 0.76 L3MBTL1 (0.62) HTTTSHRL3MBTL1ALDH1A1LMNA
SCHEMBL20074656 0.76 L3MBTL1 (0.62) HTTTSHRL3MBTL1ALDH1A1LMNA
SCHEMBL28872945 0.75 ALDH1A1 (0.52) HTTTSHRL3MBTL1ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL29681190 0.75 L3MBTL1 (0.60) HTTTSHRL3MBTL1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL29090984 0.75 L3MBTL1 (0.60) HTTTSHRL3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020041562-A1 SUBSTITUTED IMIDAZOLES FOR THE INHIBITION OF TGF-BETA AND METHODS OF TREATMENT CLAVIUS PHARMACEUTICALS, LLC (US) 2020-02-27 WO disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed